Results 11 to 20 of about 1,725 (182)

Lasers in Medicine: The Changing Role of Therapeutic Laser-Induced Retinal Damage—From de rigeuer to Nevermore

open access: yesPhotonics, 2023
For over five decades, laser-induced retinal damage (LIRD) was thought to be the necessary cost of all therapeutic effects of laser treatment for the most important causes of irreversible visual loss, the chronic progressive retinopathies (CPRs).
Jeffrey K. Luttrull
doaj   +1 more source

Comparative study between subthreshold (micropulse) laser direct application to the edematous macula versus direct application to the peripheral healthy retina in the treatment of diabetic macular edema. [PDF]

open access: yesAl-Azhar International Medical Journal, 2023
Background: Subthreshold (micropulse) laser is an effective modality in the treatment of diabetic macular edema that avoids possible complications of conventional laser photocoagulation and anti-vascular endothelial growth factor. Regardless of where the
Eslam Alharif, Hamed Taha, Mohamed Rahed
doaj   +1 more source

Topical Anesthesia Offers Sufficient Pain Control for MicroPulse Transscleral Laser Therapy for Glaucoma

open access: yesJournal of Ophthalmology, 2022
Introduction. The aim of this study was to evaluate patient pain during and after MicroPulse Transscleral Laser Therapy (TLT) and vision-related quality of life using two different anesthesia protocols: “Topical Plus” anesthesia without standby ...
Belgin Vasella, Marc Töteberg-Harms
doaj   +1 more source

Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT

open access: yesHealth Technology Assessment, 2022
Background: The National Institute for Health and Care Excellence recommends macular laser to treat diabetic macular oedema with a central retinal subfield thickness of  400 µm.
Noemi Lois   +26 more
doaj   +1 more source

A review on technology and different probes in transscleral cyclophotocoagulation

open access: yesTNOA Journal of Ophthalmic Science and Research, 2022
Glaucoma is a chronic progressive optic neuropathy, characterised by retinal ganglion cell loss leading to optic nerve head changes and visual field defects.
M Salu   +3 more
doaj   +1 more source

The efficacy of micropulse laser combined with ranibizumab in diabetic macular edema treatment: study protocol for a randomized controlled trial

open access: yesTrials, 2022
Background At present, intraocular injection of anti-VEGF (vascular endothelial growth factor) drugs has replaced traditional laser therapy as the first-line treatment for DME (diabetic macular edema). However, ranibizumab, a commonly used anti-VEGF drug,
Xuejing Mi, Xiaoya Gu, Xiaobing Yu
doaj   +1 more source

Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection

open access: yesClinical Ophthalmology, 2022
Tomas M Grippo,1 Ronald MPC de Crom,2 Michael Giovingo,3 Marc Töteberg-Harms,4 Brian A Francis,5 Brian Jerkins,6 Jacob W Brubaker,7 Nathan Radcliffe,8 Jella An,9 Robert Noecker10 1Department of Ophthalmology, Hospital Aleman, Buenos Aires, Argentina ...
Grippo TM   +9 more
doaj  

Subthreshold micropulse yellow laser in the treatment of central serous chorioretinopathy

open access: yesTNOA Journal of Ophthalmic Science and Research, 2019
Purpose: The objective was to study the safety and efficacy of subthreshold micropulse yellow laser in the treatment of central serous chorioretinopathy (CSCR).
T P Vignesh
doaj   +1 more source

Micropulse laser trabeculoplasty for open-angle glaucoma

open access: yesDelta Journal of Ophthalmology, 2016
Purpose The aim of this study was to evaluate the pressure-lowering effect of 577 nm micropulse laser trabeculoplasty in eyes treated for primary open-angle glaucoma. Patients and methods This prospective interventional case series included 30 eyes of 30
Mahmoud A Abouhussein
doaj   +1 more source

Micropulse Laser Therapy as an Integral Part of Eye Disease Management

open access: yesMedicina, 2023
Ocular diseases can significantly impact vision and quality of life through pathophysiological alterations to the structure of the eye. The management of these conditions often involves a combination of pharmaceutical interventions, surgical procedures ...
Flaviu Bodea   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy